ASAS-PerSpA study finds Japanese patients with axial psoriatic arthritis have lower disease activity and better function than ...
Growth and income investors can buy these five top dividend stocks now, tomorrow, next week, or next year and hold for the ...
Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...
AbbVie to present data from multiple studies of Rinvoq, Humira & Skyrizi at the 2019 ACR/ARP) meeting: North Chicago, Illionis Tuesday, November 5, 2019, 16:00 Hrs [IST] AbbVie, a ...